Nocturnal nondipping and left ventricular hypertrophy in hypertension: An updated review

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 6, 2010, Pages 781-792

  Cuspidi, Cesare ^a,b   Giudici, Valentina ^b   Negri, Francesca ^a,b   Sala, Carla ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Hypertension; Left ventricular hypertrophy; Nondipping

Indexed keywords

DIURETIC AGENT; DOXAZOSIN; PERINDOPRIL; PIOGLITAZONE; ROSIGLITAZONE; TELMISARTAN; VALSARTAN; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER;

BEDTIME DOSAGE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; MEDICAL DECISION MAKING; MONOTHERAPY; MORNING DOSAGE; NOCTURNAL BLOOD PRESSURE NONDIPPING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROGNOSIS; REVIEW; SLEEP PATTERN; ADULT; AGED; BLOOD PRESSURE; CLASSIFICATION; DRUG EFFECTS; HEART VENTRICLE REMODELING; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; SLEEP;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIURETICS; DRUG CHRONOTHERAPY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SLEEP; VENTRICULAR REMODELING;

EID: 77953486119     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.29     Document Type: Review

References (120)

1. Pickering TG, Hall JE, Appel LI et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans. A statement for professionals. From the subcommittee of professional and public education of the American Heart Association Council on high blood pressure research. Hypertension 45, 142-161 (2005).
2. Parati G, Mancia G. Ambulatory blood pressure monitoring in clinical practice. J. Hypertens. 20, 1925-1927 (2002). (Pubitemid 35305482)
3. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 81, 700-702 (1990).
4. Weber MA, Drayer YM, Makamura DK, Wyle FA. The circadian blood pressure pattern in ambulatory normal subjects. Am. J. Cardiol. 45, 115-119 (1994).
5. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 36, 894-900 (2000).
6. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 397, 2 (1988).
7. Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81, 528-536 (1990).
8. Pierdomenico SD, Lapenna D, Guglielmini LD et al. Arterial disease in dipper and non-dipper hypertensive patients. Am. J. Hypertens. 10, 511-518 (1997).
9. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am. J. Hypertens. 7, 23-26 (1994).
10. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J. Hypertens. 10, 875-878 (1992).
11. Ohkubo T, Hozawa A, Yamaguchi J et al. Prognostic significance of nocturnal decline in blood pressure in subjects with and without high 24-hour blood pressure: the Ohasama study. J. Hypertens. 20, 2183-2189 (2002).
12. Dolan E, Stanton A, Thijs L et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension 46, 156-161 (2005).
13. Fagard RH, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J. Hum Hypertens. 23, 645-653 (2009).
14. Cuspidi C, Lonati L, Sampieri L et al. Impact of nocturnal fall in blood pressure on early cardiovasclar changes in essential hypertension. J. Hypertens. 17, 1339-1344 (1999).
15. Grandi AM, Broggi R, Jessula A et al. Relation of extent of nocturnal blood pressure decrease to cardiovascular remodelling in never-treated patients with essential hypertension. Am. J. Cardiol. 89, 1193-1196 (2002).
16. Bjorklund K, Lind L, Andren B, Lithell H. The majority of nondipping men do not have increased cardiovascular risk: a population-based study. J. Hypertens. 20, 1501-1506 (2002).
17. Eguchi K, Ishikawa J, Hoshide S et al. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with Type 2 diabetes. Am. J. Hypertens. 22, 46-51 (2009).
18. -2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105-1187 (2007).
19. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 27, 2121-2156 (2009).
20. Bombelli M, Facchetti R, Carugo S et al. Left ventricular hypertrophy increases cardiovascular risk independently of in and out-of office blood pressure values. J. Hypertens. 27(12), 2458-2464 (2009).
21. Tsioufis C, Vezali E, Tsiachris D et al. Left ventricular hypertrophy versus chronic renal disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study. J. Hypertens. 27(4), 744-752 (2009).
22. Zanchetti A, Hennig M, Hollweck R et al. Baseline values but not treatment induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensives. Findings in the ELSA. Circulation 120, 1084-1090 (2009).
23. Ruilope LM, Zanchetti A, Julius S et al.; VALUE Investigators. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE Trial. J. Hypertens. 25, 1473-1479 (2007).
24. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am. J. Hypertens. 20, 154-161 (2007).
25. Ohkubo T, Imai Y, Tsuji I et al. Relation between nocturnal decline in blood pressure and mortality. Am. J. Hypertens. 10, 1201-1207 (1997).
26. Mancia G, Bombelli M, Facchetti R et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 49, 1265-1270 (2007).
27. Boggia J, Li Y, Thijs L et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370, 1219-1229 (2007).
28. Ingelsson E, Bjorklund-Bodegard K, Arnlov J, Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295, 2859-2866 (2006).
29. Verdecchia P, Angeli F, Borgioni C. Gattobigio R, Reboldi G. Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Hypertension 49, 777-783 (2007).
30. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 49, 1235-1241 (2007).
31. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Blunted heart rate dip during sleep and all-cause mortality. Arch. Intern. Med. 167, 2116-2121 (2007).
32. Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. J. Hypertens. 16, 1335-1343 (1998).
33. Fagard RH, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J. Hum. Hypertens. 23, 645-653 (2009).
34. Fagard RH. Dipping pattern of nocturnal blood pressure in patients with hypertension. Expert Rev. Cardiovasc. Ther. 7(6), 599-605 (2009).
35. Parati G. Blood pressure reduction at night: sleep and beyond. J. Hypertens. 16, 1725-1729 (2000).
36. Hermida RC, Ayala DE, Mojon A et al. Blood pressure patterns in normal pregnancy, gestational hypertension and preeclampsia. Hypertension 36, 149-158 (2000).
37. Akerstedt T. Altered sleep/awake patterns and circadian rhythms. Laboratory and field studies of sympathoadrenomedullary and related variables. Acta Physiol. Scand. 469, 1-48 (1979).
38. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab. 60, 1210-1215 (1985).
39. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am. J. Hypertens. 15, 111-118 (2002). (Pubitemid 34161084)
40. Grassi G, Seravalle G, Quarti-Trevano F et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension 52, 925-932 (2008).
41. Loredo JS, Ancoli-Israeli S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am. J. Hypertens. 14, 887-892 (2001).
42. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98, 772-776 (1998). (Pubitemid 28391842)
43. Suzuki M, Kimura Y, Tsushima M, Harano Y. Association of insulin resistance with salt sensitivity and nocturnal fall in blood pressure. Hypertension 35, 864-868 (2000).
44. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping and sodium sensitivity. Hypertension 24, 1627-1632 (2006).
45. Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension 51, 891-898 (2008).
46. Kimura G. Kidney and circadian blood pressure rhythm. Hypertension 51, 827-828 (2008).
47. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from non-dipper to dipper in essential hypertension. Circulation 100, 1635-1638 (1999).
48. Uzu T, Ishikawa K, Fuji T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from non-dipper in dipper in essential hypertension. Circulation 96, 1859-1862 (1997). (Pubitemid 27400745)
49. Profant J, Dimsdale JE. Race and diurnal blood pressure patterns: a review and meta-analysis. Hypertension 33, 1099-1104 (1999).
50. Hyman DJ, Ogbonnaya K, Taylor AA, Ho K, Pavlik VN. Ethnic differences in nocturnal blood pressure decline in treated hypertensives. Am. J. Hypertens. 13, 884-891 (2000).
51. Agyemang C, Bhopal R, Bruijnzeels M, Redekop WK. Does nocturnal blood pressure fall in people of African and south Asian descent differ from that in European white populations? A systematic review and meta-analysis. J. Hypertens. 23, 913-920 (2005). (Pubitemid 40637905)
52. Leary AC, Donnan PT, MacDonald TM, Murphy MB. Physical activity level is an independent predictor of the diurnal variation in blood pressure. J. Hypertens. 18, 405-410 (2000).
53. Bursztyn M, Mekler J, Wachtel N, Ben-Ishay D. Siesta and ambulatory blood pressure monitoring, comparability of the afternoon nap and night sleep. Am. J. Hypertens. 7, 217-221 (1994).
54. Stergiou GS, Malakos JS, Zourbaki AS, Achimastos AD, Mountokalakis TD. Blood pressure during siesta: effect on 24-h ambulatory blood pressure profiles analysis. J. Hum. Hypertens. 11, 125-131 (1997).
55. Perk G, Ben-Arie L, Mekler J, Bursztyn M. Dipping status may be determined by nocturnal urination. Hypertension 37, 749-752 (2001).
56. Agarwal R, Light RP, Bills JE, Hummel LA. Nocturia, nocturnal activity, and nondipping. Hypertension 54, 646-651 (2009).
57. James MA, Fotherby MD, Potter JF. Reproducibility of the circadian systolic blood pressure variation in the elderly. J. Hypertens. 13, 1097-1113 (1995).
58. Dimsdale JE, Heeren MM. How reliable is nighttime blood pressure dipping? Am. J. Hypertens. 11, 606-609 (1998).
59. Mochizuchi Y, Okutani M, Donfeng Y et al. Limited reproducibility of circadian variation in blood pressure dippers and non dippers. Am. J. Hypertens. 11, 403-409 (1998).
60. van der Steen MS, Lenders JWM, Graafsma SJ, den Arend J, Thien T. Reproducibility of ambulatory blood pressure monitoring in daily practice. J. Hum. Hypetens. 13, 303-308 (1999).
61. Cuspidi C, Meani S, Salerno M et al. Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: a prospective observational study. J. Hum. Hypertens. 18, 503-509 (2004).
62. Hernandez-del-Rey R, Martin-Baranera M, Sobrino J et al. Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish Ambulatory Blood Pressure Monitoring Registry. J. Hypertens. 25, 2406-2412 (2007).
63. Omboni S, Parati G, Palatini P et al. Reproducibility and clinical value of nocturnal hypotension, prospective evidence from the SAMPLE Study. J. Hypertens. 16, 733-738 (1998). (Pubitemid 28247955)
64. Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am. J. Hypertens. 13, 1035-1038 (2000).
65. Ben-Dov IZ, Ben-Arieh L, Mekler J, Bursztyn M. Blood pressure dipping is reproducible in clinical practice. Blood Press. Monit. 10, 79-84 (2005).
66. Heskens LH, Kroon AA, Oostenbrugge RJ, Haest RJ, Lodden J, de Leeuw PW. Different classifications affect the prevalence of dippers and non-dippers and the relation with target-organ damage. J. Hypertens. 26, 691-698 (2008).
67. Palatini P, Mormino P, Canali C et al. Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Hypertension 23, 211-216 (1994).
68. Cuspidi C, Meani S, Valerio C et al. Reproducibility of dipping/nondipping pattern in untreated essential hypertensives: impact of age and sex. Blood Press. Monit. 12, 101-106 (2007).
69. Lurbe E, Redon J, Pascual JM, Tacons J, Alvarez V. The spectrum of circadian blood pressure changes in Type 1 diabetics. J. Hypertens. 19, 1421-1429 (2001).
70. Cuspidi C, Meani S, Lonati L et al. Short-term reproducibility of a non-dipping pattern in Type 2 diabetic hypertensive patients. J. Hypertens. 24, 647-653 (2006).
71. Cuspidi C, Negri F, Giudici V et al. Echocardiography in clinical practice: the burden of arterial hypertension. A multicenter Italian Survey. J. Hum. Hypertens. DOI: 10.1038/jhh.2009.78 (2009) (Epub ahead of print).
72. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am. Heart J. 141, 334-341 (2001).
73. Havranek EP, Froshaug DB, Enserman CDB et al. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am. J. Med. 121, 870-875 (2008).
74. Milani RV, Lavie CJ, Mehera MR, Ventura HO, Kartz JD, Messerli F. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am. J. Cardiol. 97, 959-963 (2006).
75. Schmieder RE. The role on non-haemodynamic factors in the genesis of LVH. Nephrol. Dial. Transplant. 20, 2610-2612 (2005).
76. Cuspidi C, Ciulla M, Zanchetti. Hypertensive myocardial fibrosis. Nephrol. Dial. Transplant. 21, 20-23 (2006).
77. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J. Hypertens. 16, 1031-1041 (1998).
78. Diez J. Towards a new paradigm about hypertensive heart disease. Med. Clin. North Am. 93, 637-645 (2009).
79. Diez J. Mechanisms of cardiac fibrosis in hypertension. J. Clin. Hypertens. 7, 546-550 (2007).
80. Rowlands DB, Glover DR, Ireland MA et al. Assessment of left ventricular mass and in response to antihypertensive treatment. Lancet 1(8270), 467-470 (1982).
81. Devereux RB, Pickering TG, Harshfield GA et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 68, 470-476 (1983).
82. Mancia G, Zanchetti A, Agabiti-Rosei E et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-related regression of left ventricular hypertrophy. Circulation 95, 1464-1470 (1997).
83. Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Porcellati C. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J. Hypertens 10, 683-692 (1992).
84. Routledge FS, McFetridge-Durdle JA, Dean CR. Night-time blood pressure patterns and target organ damage: a review. Can. J. Cardiol. 23, 132-138 (2007).
85. Fagard R, Staessen JA, Thijs L. The relationship between left ventricular mass and night-time and day-time blood pressures: a meta-analysis. J. Hypertens. 13, 823-829 (1995).
86. Rizzo V, Di Maio F, Villatico-Campbell S et al. Left ventricular function, cardiac dysrhythmias, atrial activation, and volumes in nondipper hypertensive individuals with left ventricular hypertrophy. Am. Heart J. 139, 529-536 (2000).
87. Ijri H, Kohno I, Yin D et al. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension. Jpn Circ. J. 64, 499-504 (2000).
88. Passino C, Magagna A, Conforti F et al. Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J. Hypertens. 21, 445-451 (2003).
89. Cuspidi C, Meani S, Salerno M et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J. Hypertens. 22, 273-280 (2004).
90. Balci B, Yilmaz O, Yesildag O. The influence of ambulatory blood pressure profile on left ventricular geometry. Echocardiography 21, 7-10 (2004).
91. Felicio JS, Pacheco JT, Ferreira SR et al. Hyperglycemia and nocturnal blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovasc. Diabetol. 5, 19-25 (2006).
92. Perez-Lloret S, Tobili JE, Cardinali DP, Malateste JC, Milei J. Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping. Int. J. Cardiol. 127, 387-389 (2008).
93. Kristensen KS, Hoegholm A, Bang LA, Gustavsen PH, Poulsen CB. No impact of blood pressure variability on microalbuminuria and left ventricular geometry: analysis of daytime variation, diurnal variation and white coat effect. Blood Press. Monit. 6, 125-131 (2001).
94. Salvetti M, Muiesan ML, Rizzoni D et al. Nighttime blood pressure and cardiovascular structure in a middle-aged general population in the Northen Italy: the Vobarno Study. J. Hum. Hypertens. 15, 879-885 (2001).
95. Tsioufis C, Antoniadis D, Stefanadis C et al. Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am. J. Hypertens. 15, 600-604 (2002).
96. Cicconetti P, Morelli S, De Serra C et al. Left ventricular mass in dippers nondippers with newly diagnosed hypertension. Angiology 54, 661-669 (2003).
97. Della Mea P, Lupia M, Bandolin V et al. Adiponectin, insulin resistance, and left ventricular structure in dipper and non dipper essential hypertensive patients. Am. J. Hypertens. 18, 30-35 (2005).
98. Cuspidi C, Michev I, Meani S et al. Non-dipper treated hypertensive patients do not have increate cardiac structural alterations. Cardiovasc. Ultrasound 1, 1-7 (2003).
99. Cicconetti P, Morelli S, Ottaviani L et al. Blunted nocturnal fall in blood pressure and left ventricular mass in elderly individuals with recently diagnosed isolated systolic hypertension. Am. J. Hypertens. 16, 900-905 (2003).
100. Iida T, Kohno I, Fujoka D et al. Blunted reduction of pulse pressure during nighttime is associated with left ventricular hypertrophy in elderly patients. Hypertens. Res. 27, 573-579 (2004).
101. Morfis L, Butler SP, Shnier RC, Howes LG. Nocturnal blood pressure predicts left ventricular mass index in normotensive elderly. Blood Press. 11, 18-21 (2002).
102. Hoshide S, Kario K, Hoshide Y et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens. 16, 434-438 (2003).
103. Hinderliter AL, Blumenthal JA, Waugh R, Chilukuri M, Sherwood A. Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation. Am. J. Hypertens. 17, 43-49 (2004).
104. Iantorno M, Pola R, Schinzani F et al. Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension. Cardiology 100, 114-119 (2003).
105. Nishikimi T, Minami J, Tamano K et al. Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-h blood pressure study. Hypertens. Res. 24, 507-514 (2001).
106. Fagugli RM, Quintiliani G, Pasini P et al. Blunted nocturnal blood pressure decrease and left ventricular mass in hypertensive hemodialysis patients. Nephron 91, 79-85 (2002).
107. Rahaman M, Grifin V, Heyka R, Hoit B. Diurnal variation of blood pressure; reproducibility and association with left ventricular hypertrophy in hemodialysis patients. Blood Press. Monit. 10, 25-32 (2005).
108. Toprak A, Koc M, Tezcan H, Ozener IC, Oktay A, Akoglu E. Night-time blood pressure load is associated with higher left ventricular mass index in renal transplant recipients. J. Hum. Hypertens. 17, 239-244 (2003).
109. Pogue V, Rahaman M, Lipkowitz M et al. for the African American Study of Kidney Disease and Hypertension Collaborative Research Group. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53, 20-27 (2009).
110. Mancia G, Sega R, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J. Hypertens. 13, 1377-1390 (1995).
111. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of a-adrenergic blocker, doxazosin. Results from the HALT study. Hypertension 35, 787-794 (2000).
112. Hermida RC, Calvo C, Ayala DE et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J. Hypertens. 10, 1913-1922 (2005).
113. Anan F, Takahashi N, Ooie T et al. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic stiffness in patients with essential hypertension. Eur. J. Clin. Pharmacol. 61, 353-359 (2005).
114. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50, 715-722 (2007).
115. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51, 69-76 (2008).
116. Uzu T, Sakaguchi M, Yokomaku Y et al. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in Type 2 diabetic patients treated with an angiotensin II receptor blocker. Clin. Exp. Nephrol. 4, 300-306 (2009).
117. Ko GT, Chan HC. Restoration of nocturnal dip in blood pressure is associated with improvement in left ventricular ejection fraction. A 1-year clinical study comparing the effects of amlodipine and nifedipine retard on ambulatory blood pressure and left ventricular systolic function in Chinese hypertensive Type 2 diabetic patients. Int. J. Cardiol. 89, 159-166 (2003).
118. Negro R, Mangieri T, Dazzi D, Pezzarossa A, Hassan H. Rosiglitazone effects on blood pressure and metabolic parameters in non dipper diabetic patients. Diabetes Res. Clin. Pract. 70, 20-25 (2005).
119. Anan F, Masaki T, Fakunaga N et al. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in Type 2 diabetes mellitus. Eur. J. Clin. Invest. 37, 709-714 (2007).
120. Palatini P, Parati G. Modulation of 24-h blood pressure profiles: a new target for treatment. J. Hypertens. 23, 1799 - 1801 (2005).